Does betamethasone therapy impact fetal multivessel Doppler parameters?

Halis Özdemir, Kemal Hansu, P. Calis, D. Karçaaltıncaba, M. Bayram
{"title":"Does betamethasone therapy impact fetal multivessel Doppler parameters?","authors":"Halis Özdemir, Kemal Hansu, P. Calis, D. Karçaaltıncaba, M. Bayram","doi":"10.5114/pcard.2021.109175","DOIUrl":null,"url":null,"abstract":"Introduction: The objective of this study was to test the hypothesis that antenatal corticosteroid therapy alters fetal cardiopulmonary and uteroplacental blood flow in pregnancies. Material and methods: Twenty-seven singleton pregnancies between 28 and 34 gestational weeks classified as at risk of preterm birth were included prospectively. We evaluated fetal main pulmonary artery (MPA), left and right pulmonary artery (PA), left myocardial performance index (Tei index), tricuspid valve (TV), umbilical artery (UmA), middle cerebral artery (MCA), and ductus venosus (DV) parameters before and 48 hours and 7 days after antenatal steroid administration. Results: The mean age was 31 years, and the mean gestational age was 31 weeks. The UmA S/D (Systole/Diastole) ratio, PI (pulsatility index) and RI (resistive index) values, and Doppler parameters of other vessels were not different when comparing between before and after steroid administration. Except for MCA PSV (peak systolic velocity) values, the other MCA Doppler parameters (S/D, PI, RI) were all significantly decreased. The cerebroplacental ratio (CPR) and CPR percentile values decreased significantly. All tested cardiac parameters were unchanged, except MPA ejection time (ET) ( p = 0.016). Conclusions: Our data demonstrate altered fetal MCA and CPR with corticosteroid therapy. These data suggest that antenatal corticosteroid therapy has no impact on any Doppler parameters of fetal cardiopulmonary and uteroplacental blood flow in pregnancies.","PeriodicalId":415760,"journal":{"name":"Prenatal Cardiology","volume":"16 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prenatal Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/pcard.2021.109175","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: The objective of this study was to test the hypothesis that antenatal corticosteroid therapy alters fetal cardiopulmonary and uteroplacental blood flow in pregnancies. Material and methods: Twenty-seven singleton pregnancies between 28 and 34 gestational weeks classified as at risk of preterm birth were included prospectively. We evaluated fetal main pulmonary artery (MPA), left and right pulmonary artery (PA), left myocardial performance index (Tei index), tricuspid valve (TV), umbilical artery (UmA), middle cerebral artery (MCA), and ductus venosus (DV) parameters before and 48 hours and 7 days after antenatal steroid administration. Results: The mean age was 31 years, and the mean gestational age was 31 weeks. The UmA S/D (Systole/Diastole) ratio, PI (pulsatility index) and RI (resistive index) values, and Doppler parameters of other vessels were not different when comparing between before and after steroid administration. Except for MCA PSV (peak systolic velocity) values, the other MCA Doppler parameters (S/D, PI, RI) were all significantly decreased. The cerebroplacental ratio (CPR) and CPR percentile values decreased significantly. All tested cardiac parameters were unchanged, except MPA ejection time (ET) ( p = 0.016). Conclusions: Our data demonstrate altered fetal MCA and CPR with corticosteroid therapy. These data suggest that antenatal corticosteroid therapy has no impact on any Doppler parameters of fetal cardiopulmonary and uteroplacental blood flow in pregnancies.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
倍他米松治疗是否影响胎儿多普勒血管参数?
前言:本研究的目的是验证产前皮质类固醇治疗改变妊娠期胎儿心肺和子宫胎盘血流的假设。材料和方法:前瞻性纳入27例孕周28 ~ 34周有早产风险的单胎妊娠。我们在给药前、48小时和7天后评估胎儿肺动脉主动脉(MPA)、左右肺动脉(PA)、左心肌功能指数(Tei index)、三尖瓣(TV)、脐动脉(UmA)、大脑中动脉(MCA)和静脉导管(DV)参数。结果:平均年龄31岁,平均孕周31周。类固醇给药前后,其他血管的收缩期/舒张期(UmA) S/D比值、脉搏指数(PI)和阻力指数(RI)值及多普勒参数均无差异。除MCA PSV(峰值收缩速度)值外,其他MCA多普勒参数(S/D、PI、RI)均显著降低。脑胎盘比(CPR)和CPR百分位数值明显下降。除MPA射血时间(ET)外,所有心脏参数均无变化(p = 0.016)。结论:我们的数据表明,皮质类固醇治疗可改变胎儿MCA和CPR。这些数据表明,产前皮质类固醇治疗对妊娠期间胎儿心肺和子宫胎盘血流的任何多普勒参数没有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Extraordinary Bulging Mass in the Foetus - A Case Report of Bladder Exstrophy Prenatal Detection and Postnatal Verification of Unusual Intracardiac Total Anomolous Pulmonary Venous Connection (Tapvc) in Complex Heart Defect with Dextrocardia - Case Report Isolated Double Aortic Arch (Daa) – Prenatal Detection with Postnatal Follow-Up, Case Report and Literature Review Prenatal Microcephaly and Hydrocephalus and Normal Heart Anatomy, Postnatal Diagnosis of Nijmegen Syndrome - Case Report Congenital Heart Defects Coexisting with Omphalocele - the Important Prognostic Factor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1